Skip to main content
Elsevier

Biomarkers in Heart Failure, An Issue of Heart Failure Clinics

  • 1st Edition, Volume 5-4 - September 2, 2009
  • Latest edition
  • Author: Eugene Braunwald
  • Language: English

Biomarkers — which may be enzymes, hormones, biologic substances, or other markers of cardiac stress and malfunction — appear to have growing clinical importance in heart failure.… Read more

Purchase options

Info / Buy

Description

Biomarkers — which may be enzymes, hormones, biologic substances, or other markers of cardiac stress and malfunction — appear to have growing clinical importance in heart failure. Many biomarkers appear to provide important information about the cause of heart failure or the identification of those at risk for heart failure or appear to be useful in risk stratification, in the diagnosis of heart failure, or in monitoring therapy. This issue discusses the current and potential future role of biomarkers and includes articles that explore individual biomarkers in depth.

Product details

  • Edition: 1
  • Latest edition
  • Volume: 5-4
  • Published: September 2, 2009
  • Language: English

About the author

EB

Eugene Braunwald

Dr. Eugene Braunwald, an Elsevier Author, is considered the leading name in cardiology and his research has expanded knowledge and understanding in the areas of congestive heart failure, coronary artery disease, and valvular heart disease. He has authored more than 1400 medical articles and his textbook, Braunwald’s Heart Disease, is cited worldwide and recognized as the best book on the subject.
Affiliations and expertise
Distinguished Hersey Professor of Medicine, Harvard Medical School, Founding Chairman, TIMI Study Group, Brigham and Women ’s Hospital, Boston, Massachusetts, USA